Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Maryland, Baltimore
Children's Oncology Group
Centre Antoine Lacassagne
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Southern California
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Dana-Farber Cancer Institute
Jiangsu Hansoh Pharmaceutical Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
National Cancer Institute (NCI)
Bristol-Myers Squibb
Children's Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Academic and Community Cancer Research United
National Cancer Institute (NCI)
University of Nebraska
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, Irvine
National Cancer Institute (NCI)
GOG Foundation
Virginia Commonwealth University
Yale University